Pfizer and Flagship Pioneering Expand Partnership with Two New Biotechnology Agreements
CompanyDeals

Pfizer and Flagship Pioneering Expand Partnership with Two New Biotechnology Agreements

Easton Pharmaceutical Secures NMPA Approval for Generic Jakavi and Urocit-K
CompanyDrug

Easton Pharmaceutical Secures NMPA Approval for Generic Jakavi and Urocit-K

Innorna's mRNA Drug IN015 Earns Orphan Drug Designation for PFIC Treatment
CompanyDrug

Innorna’s mRNA Drug IN015 Earns Orphan Drug Designation for PFIC Treatment

Kura Oncology and Kyowa Kirin Ink Licensing Deal for Menin Inhibitor Ziftomenib
CompanyDeals

Kura Oncology and Kyowa Kirin Ink Licensing Deal for Menin Inhibitor Ziftomenib

Jiangsu Hengrui Receives NMPA Approval for HRS-6208 Solid Tumor Clinical Study
CompanyDrug

Jiangsu Hengrui Receives NMPA Approval for HRS-6208 Solid Tumor Clinical Study

CR Pharma's CR Sanjiu to Sell 51% Stake in Shenghuo for RMB 1.791 Billion
CompanyDeals

CR Pharma’s CR Sanjiu to Sell 51% Stake in Shenghuo for RMB 1.791 Billion

InxMed's Ifebemtinib Earns Breakthrough Therapy Designation for NSCLC Treatment in China
CompanyDrug

InxMed’s Ifebemtinib Earns Breakthrough Therapy Designation for NSCLC Treatment in China

Novartis Expands Gene Therapy Portfolio with Acquisition of Kate Therapeutics
CompanyDeals

Novartis Expands Gene Therapy Portfolio with Acquisition of Kate Therapeutics

Hua Medicine and Bayer AG Terminate Co-promotion Agreement for HuaTangNing
CompanyDeals

Hua Medicine and Bayer AG Terminate Co-promotion Agreement for HuaTangNing

United Imaging Installs AI-Powered uMR OMEGA at XRANM's Breast Health Center
CompanyMedical Device

United Imaging Installs AI-Powered uMR OMEGA at XRANM’s Breast Health Center

Sino Biopharmaceutical Submits NDA for Anlotinib and Penpulimab Combo in HCC to NMPA
CompanyDrug

Sino Biopharmaceutical Submits NDA for Anlotinib and Penpulimab Combo in HCC to NMPA

Sihuan Pharmaceutical's Huisheng Pharm Strikes Exclusive Deal for Semaglutide Biosimilar in China
CompanyDeals

Sihuan Pharmaceutical’s Huisheng Pharm Strikes Exclusive Deal for Semaglutide Biosimilar in China